Navigation Links
Sanofi-Aventis Announces Approval and Closing of BMP Sunstone Acquisition Creating a Strong Consumer Health Care Platform in China
Date:2/24/2011

NEW YORK and PARIS, Feb. 24, 2011 /PRNewswire-Asia-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN; NYSE: SNY) today announced that it has completed the previously announced acquisition of BMP Sunstone Corporation (NASDAQ: BJGP). At a special meeting of stockholders held today, BMP Sunstone stockholders approved the adoption of the merger agreement among BMP Sunstone, sanofi-aventis and Star 2010, Inc., a wholly owned subsidiary of sanofi-aventis, dated October 28, 2010, as amended on November 22, 2010.  Following the special meeting, the merger was completed.

Pursuant to the merger agreement, BMP Sunstone stockholders will receive USD 10.00 per share in cash for each share of common stock they owned immediately prior to the effective time of the merger. Stockholders of record will receive a letter of transmittal and instructions on how to surrender their shares of BMP Sunstone common stock to the paying agent in exchange for the merger consideration.

With the closing of the merger, BMP Sunstone common stock will no longer trade on the NASDAQ Global Market following today's market close and will be delisted.

Morgan, Lewis & Bockius LLP served as counsel to BMP Sunstone. Stephens Inc. acted as financial advisor to BMP Sunstone.  Shearman & Sterling LLP served as counsel to sanofi-aventis. Morgan Stanley acted as financial advisor to sanofi-aventis.

About BMP SunstoneBMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Through Sunstone the Company manufactures leading pediatric and women's health products sold in pharmacies throughout the country. The Company also markets a portfolio of products under exclusive multi-year licenses into China, primarily focused on women's health and pediatrics, as well as provides pharmaceutical distribution services through subsidiaries in Beijing and Shanghai. BMP Sunstone's main office is in Beijing, with a U.S. office in Plymouth Meeting, PA.

About sanofi-aventisSanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).  For more information, please visit www.sanofi-aventis.com.Contacts for sanofi-aventis:Media Contact:Investor Contact: Jean-Marc Podvin

Sebastien MartelTel: +33 1 53 77 44 50

Tel: +33 1 53 77 45 45Email: MR@sanofi-aventis.com

Email: IR@sanofi-aventis.com Contacts for BMP Sunstone:Media Contact:Investor Contact: Fred M. Powell

ICR, LLC (Investor Relations)Tel: +1-610-940-1675

Ashley M. AmmonEmail: fpowell@bmpsunstone.com

Tel: +1-646-277-1227
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right
2. Sanofi-aventis and Sunnybrook Health Sciences Centre Agree to Develop Treatment for Diabetic Foot Ulcers
3. Sanofi-aventis Reports Top-line Results from Phase III Study with Iniparib (BSI-201) in Metastatic Triple-Negative Breast Cancer
4. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
5. Sanofi-aventis Oncology Data to be Presented at San Antonio Breast Cancer Symposium
6. Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
7. Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
8. Sanofi-aventis to Acquire BMP Sunstone Creating a Strong Consumer Healthcare Platform in China
9. Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
10. Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash
11. Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... today announced that it will be participating in the ... the InterContinental Hotel in Boston, Massachusetts ... present at 11:20 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  ...
(Date:4/20/2017)... 2017  CVS Pharmacy, the retail division of ... store design to enhance the retail customer experience ... products and expanded beauty selections paired with informational ... new offerings. Together with its innovative digital programs, ... customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... PARIS , April 20, 2017 ... EyeCET platform, the first non-viral gene expression technology that ... in the eye to address a wide range of ... UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... ...
Breaking Medicine Technology:
(Date:4/23/2017)... ... April 23, 2017 , ... Altura Communication Solutions, a nationwide ... Select certification and SMB specialization. Altura is now qualified to sell, install ... the Select Certification, Altura fulfilled the training and exam requirements for the Cisco ...
(Date:4/22/2017)... ... April 22, 2017 , ... ... named PROSHRED® Security of Philadelphia its “Woman-Owned Small Business of the ... in providing information destruction , recycling, and compliance services to businesses ...
(Date:4/22/2017)... ... April 22, 2017 , ... ... role as Vice President of Sales and Business Development at OAKWORKS, Inc. ... partner engagements, business development, and strategic planning for the company. Recognized industry-wide ...
(Date:4/21/2017)... ... 21, 2017 , ... An April 10 article in the Daily ... reveal a great deal about prehistoric ice-age dental practitioners and their primitive and, no ... to remove decayed dental matter, and that teeth were then filled with bitumen, a ...
(Date:4/21/2017)... ... ... staff at Palm Beach Face is proud to announce that their practice founder, Michael ... take place on April 23rd, the London Marathon has a long tradition of raising funds ... team EMPOWER, raising money for the international charity, Smile Train. , Started in ...
Breaking Medicine News(10 mins):